| Dr Kevin Scott Borchard, MD | |
|
785 Russell St, Craig, CO 81625-2019 | |
| (970) 826-2400 | |
| (970) 826-2429 |
| Full Name | Dr Kevin Scott Borchard |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 785 Russell St, Craig, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760686539 | NPI | - | NPPES |
| 43257356 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 45733 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastern Rio Blanco County Health Service District | Meeker, CO | Hospital |
| Memorial Hospital, The | Craig, CO | Hospital |
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Montrose Memorial Hospital | Montrose, CO | Hospital |
| Uchealth Yampa Valley Medical Center | Steamboat springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Rio Blanco County Health Service District | 0345249751 | 33 |
News Archive
In exploring how proteins interact with crucial DNA sequences to regulate gene activity, researchers have shed light on key biological events that may eventually be manipulated to provide new disease treatments.
Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.
Ob-gyns are uniquely positioned to play a major role in reducing the effects of toxic chemicals on women and babies, according to an analysis led by University of California, San Francisco (UCSF) researchers.
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has enhanced its cardiac safety capabilities for early phase clinical development through an alliance with Mortara Instrument, Inc., which manufactures and distributes electrocardiogram (ECG) devices and related technology worldwide.
› Verified 1 days ago
| Entity Name | Eastern Rio Blanco County Health Service District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902900269 PECOS PAC ID: 0345249751 Enrollment ID: O20070314000258 |
News Archive
In exploring how proteins interact with crucial DNA sequences to regulate gene activity, researchers have shed light on key biological events that may eventually be manipulated to provide new disease treatments.
Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.
Ob-gyns are uniquely positioned to play a major role in reducing the effects of toxic chemicals on women and babies, according to an analysis led by University of California, San Francisco (UCSF) researchers.
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has enhanced its cardiac safety capabilities for early phase clinical development through an alliance with Mortara Instrument, Inc., which manufactures and distributes electrocardiogram (ECG) devices and related technology worldwide.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Scott Borchard, MD 785 Russell St, Craig, CO 81625-2019 Ph: (970) 826-2400 | Dr Kevin Scott Borchard, MD 785 Russell St, Craig, CO 81625-2019 Ph: (970) 826-2400 |
News Archive
In exploring how proteins interact with crucial DNA sequences to regulate gene activity, researchers have shed light on key biological events that may eventually be manipulated to provide new disease treatments.
Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.
Ob-gyns are uniquely positioned to play a major role in reducing the effects of toxic chemicals on women and babies, according to an analysis led by University of California, San Francisco (UCSF) researchers.
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has enhanced its cardiac safety capabilities for early phase clinical development through an alliance with Mortara Instrument, Inc., which manufactures and distributes electrocardiogram (ECG) devices and related technology worldwide.
› Verified 1 days ago